Bmi-1 over-expression plays a secondary role in chronic myeloid leukemia transformation

References

• Jacobs J J, Kieboom K, Marino S, DePinho R A, van Lohuizen M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999; 397: 164–168
   PubMed Web of Science ®Google Scholar
• Jacobs J J, Scheijen B, Voncken J W, Kieboom K, Berns A, van Lohuizen M. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 1999; 13: 2678–2690
   PubMed Web of Science ®Google Scholar
• van Kemenade F J, Raaphorst F M, Blokzijl T, Fieret E, Hamer K M, Satijn D P, et al. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 2001; 97: 3896–3901
   PubMed Web of Science ®Google Scholar
• Vonlanthen S, Heighway J, Altermatt H J, Gugger M, Kappeler A, Borner M M, et al. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 2001; 84: 1372–1376
   PubMed Web of Science ®Google Scholar
• Bea S, Tort F, Pinyol M, Puig X, Hernandez L, Hernandez S, et al. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res 2001; 61: 2409–2412
   PubMed Web of Science ®Google Scholar
• Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003; 423: 255–260
   PubMed Web of Science ®Google Scholar
• Park I K, Qian D, Kiel M, Becker M W, Pihalja M, Weissman I L, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003; 423: 302–305
   PubMed Web of Science ®Google Scholar
• Shah N P, Tran C, Lee F Y, Chen P, Norris D, Sawyers C L. Overriding imatinib resistance with a novel ABL kinase inhibitor. Science 2004; 305: 399–401
   PubMed Web of Science ®Google Scholar
• Weisberg E, Manley P W, Breitenstein W, Bruggen J, Cowan-Jacob S W, Ray A, et al. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell 2005; 7: 129–141
   PubMed Web of Science ®Google Scholar
• Gumireddy K, Baker S J, Cosenza S C, John P, Kang A D, Robell K A, et al. A non-ATP-competitive inhibitor of BCR-ABL overrides imatinib resistance. Proc Natl Acad Sci USA 2005; 102: 1992–1997
   PubMed Web of Science ®Google Scholar
• Wolff N C, Veach D R, Tong W P, Bornmann W G, Clarkson B, Ilaria R L, Jr. PD166326, a novel tyrosine kinase inhibitor, has greater antileukemic activity than imatinib mesylate in a murine model of chronic myeloid leukemia. Blood 2005; 105: 3995–4003
   PubMed Web of Science ®Google Scholar
• Scherr M, Battmer K, Winkler T, Heidenreich O, Ganser A, Eder M. Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood 2003; 101: 1566–1568
   PubMed Web of Science ®Google Scholar
• Merkerova M, Bruchova H, Brdicka R. Specific silencing of PCNA gene expression in leukemic cell lines using siRNA. Cas Lek Cesk 2005; 144: 472–475
   PubMedGoogle Scholar
• Chomczynsky P, Sacchi N. Single step method of RNA isolation by acid guanidin-isothiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Molofsky A V, Pardal R, Iwashita T, Park I K, Clarke M F, Morrison S J. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003; 425: 962–967
   PubMed Web of Science ®Google Scholar
• Brisson M, Nguyen T, Vogt A, Yalowich J, Giorgianni A, Tobi D, et al. Discovery and characterization of novel small molecule inhibitors of human Cdc25B dual specificity phosphatase. Mol Pharmacol 2004; 66: 824–833
   PubMed Web of Science ®Google Scholar
• Gasparotto D, Maestro R, Piccinin S, Vukosavljevic T, Barzan L, Sulfaro S, et al. Overexpression of CDC25A and CDC25B in head and neck cancers. Cancer Res 1997; 57: 2366–2368
   PubMed Web of Science ®Google Scholar
• Liu X, Erikson R L. Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells. Proc Natl Acad Sci USA 2003; 100: 5789–5794
   PubMed Web of Science ®Google Scholar
• Zhu Y Y, Shi J M, Sun J, Lan J P, Lai X Y, Li J Y, et al. Expression of Pin1 in malignant hematopoietic cells and its relation with cell cycle. Zhejiang Da Xue Xue Bao Yi Xue Ban 2004; 33: 500–503
   PubMedGoogle Scholar
• Ranger A M, Zha J, Harada H, Datta S R, Danial N N, Gilmore A P, et al. Bad-deficient mice develop diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2003; 100: 9324–9329
   PubMed Web of Science ®Google Scholar
• Wu G S, Burns T F, McDonald E R, III, Jiang W, Meng R, Krantz I D, et al. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 1997; 17: 141–143
   PubMed Web of Science ®Google Scholar
• Paulson Q X, McArthur M J, Johnson D G. E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model. Cell Cycle 2006; 5: 184–190
   PubMed Web of Science ®Google Scholar
• Nicolas E, Morales V, Magnaghi-Jaulin L, Harel-Bellan A, Richard-Foy H, Trouche D. RbAp48 belongs to the histone deacetylase complex that associates with the retinoblastoma protein. J Biol Chem 2000; 275: 9797–9804
   PubMed Web of Science ®Google Scholar
• Huang P, Feng L, Oldham E A, Keating M J, Plunkett W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000; 407: 390–395
   PubMed Web of Science ®Google Scholar
• Davies A A, Masson J Y, McIlwraith M J, Stasiak A Z, Stasiak A, Venkitaraman A R, et al. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol Cell 2001; 7: 273–282
   PubMed Web of Science ®Google Scholar
• Liu S, Dontu G, Wicha M S. Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res 2005; 7: 86–95
   PubMed Web of Science ®Google Scholar
• Menard S, Tagliabue E, Colnaghi M I. The 67 kDa laminin receptor as a prognostic factor in human cancer. Breast Cancer Res Treat 1998; 52: 137–145
   PubMed Web of Science ®Google Scholar
• Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci 2003; 94: 575–581
   PubMed Web of Science ®Google Scholar